Ulixertinib(BVD-523)

英文名： Ulixertinib(BVD-523)

别名： 4-[5-氯-2-[(1-甲基乙基)氨基]-4-吡啶基]-N-[(1S)-1-(3-氯苯基)-2-羟基乙基]-1H-吡咯-2-甲酰胺;VRT752271 抑制剂;(S)-4-(5-氯-2-(异丙胺基)吡啶-4-基)-N-(1-(3-氯苯基)-2-羟乙基)-1H-吡咯-2-酰胺 4-[5-氯-2-[(1-甲基乙基)氨基]-4-吡啶基]-N-[(1S)-1-(3-氯苯基)-2-羟基乙基]-1H-吡咯-2-甲酰胺;VRT752271 抑制剂;(S)-4-(5-氯-2-(异丙胺基)吡啶-4-基)-N-(1-(3-氯苯基)-2-羟乙基)-1H-吡咯-2-酰胺展开

CAS No. : 869886-67-9

分子式 : C₂₁H₂₂Cl₂N₄O₂

分子量 : 433.33

大包装询价? 收藏产品

中文名称	Ulixertinib(BVD-523)
中文别名	4-[5-氯-2-[(1-甲基乙基)氨基]-4-吡啶基]-N-[(1S)-1-(3-氯苯基)-2-羟基乙基]-1H-吡咯-2-甲酰胺;VRT752271 抑制剂;(S)-4-(5-氯-2-(异丙胺基)吡啶-4-基)-N-(1-(3-氯苯基)-2-羟乙基)-1H-吡咯-2-酰胺
英文名称	Ulixertinib(BVD-523)
英文别名	VRT752271;Ulixertinib;N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-4-[5-chloro-2-(propan-2-ylamino)pyridin-4-yl]-1H-pyrrole-2-carboxamide;VRT-752271;Ulixertinib [INN];16ZDH50O1U;Ulixertinib (INN);4-[5-chloranyl-2-(propan-2-ylamino)pyridin-4-yl]-~{N}-[(1~{S})-1-(3-chlorophenyl)-2-oxidanyl-ethyl]-1~{H}-pyrrole-2-carboxamide;GTPL9210;4-[5-Chloro-2-[(1-methylethyl)amino]-4-pyridinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide (ACI);(S)-4-(5-Chloro-2-(isopropylamino)pyridin-4-yl)-N-(1-(3-chlorophenyl)-2-hydroxyethyl)-1H-pyrrole-2-carboxamide;BVD 523;VRT 752271;Z2756516977;EX-A1332;EX-A1332;HY-15816;HY-15816;HY-15816;Ulixertinib (BVD-523, VRT752271);Ulixertinib (BVD-523, VRT752271);Ulixertinib (BVD-523, VRT752271);s7854;s7854;s7854;BRD-K28965160-001-01-1;BRD-K28965160-001-01-1;BRD-K28965160-001-01-1;BCP04232;BCP04232;BCP04232;CHEMBL3590106;CHEMBL3590106;CHEMBL3590106;D11038;D11038;D11038;AKOS025396467;AKOS025396467;AKOS025396467;869886-67-9;869886-67-9;869886-67-9;AC-33165;AC-33165;AC-33165;VRT752271 HCl;VRT752271 HCl;VRT752271 HCl;4-{5-chloro-2-[(propan-2-yl)amino]pyridin-4-yl}-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide;4-{5-chloro-2-[(propan-2-yl)amino]pyridin-4-yl}-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide;4-{5-chloro-2-[(propan-2-yl)amino]pyridin-4-yl}-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide;NSC800959;NSC800959;NSC800959;Ulixertinib (BVD-523);Ulixertinib (BVD-523);Ulixertinib (BVD-523);DB13930;DB13930;DB13930;BCP0726000085;BCP0726000085;BCP0726000085;ULIXERTINIB [WHO-DD];ULIXERTINIB [WHO-DD];ULIXERTINIB [WHO-DD];BVD-ERK;BVD-ERK;BVD-ERK;BVD-523 HCl;BVD-523 HCl;CCG-269049;BVD-523 HCl;CCG-269049;1H-Pyrrole-2-carboxamide, 4-(5-chloro-2-((1-methylethyl)amino)-4-pyridinyl)-N-((1S)-1-(3-chlorophenyl)-2-hydroxyethyl)-;1H-Pyrrole-2-carboxamide, 4-(5-chloro-2-((1-methylethyl)amino)-4-pyridinyl)-N-((1S)-1-(3-chlorophenyl)-2-hydroxyethyl)-;CCG-269049;NS00072098;NS00072098;1H-Pyrrole-2-carboxamide, 4-(5-chloro-2-((1-methylethyl)amino)-4-pyridinyl)-N-((1S)-1-(3-chlorophenyl)-2-hydroxyethyl)-;BVD523 HCl;BVD523 HCl;NS00072098;SCHEMBL14211742;SCHEMBL14211742;BVD523 HCl;NSC797771;NSC797771;SCHEMBL14211742;NSC-797771;NSC-797771;NSC797771;NCGC00378692-07;NCGC00378692-07;NSC-797771;BVD-523;BVD-523;NCGC00378692-07;J-690368;J-690368;BVD-523;UNII-16ZDH50O1U;UNII-16ZDH50O1U;J-690368;G60969;G60969;ulixertinibum;UNII-16ZDH50O1U;ulixertinibum;N-((1S)-1-(3-chlorophenyl)-2-hydroxyethyl)-4-(5-chloro-2-(propan-2-ylamino)pyridin-4-yl)-1H-pyrrole-2-carboxamide;G60969;NSC-800959;N-((1S)-1-(3-chlorophenyl)-2-hydroxyethyl)-4-(5-chloro-2-(propan-2-ylamino)pyridin-4-yl)-1H-pyrrole-2-carboxamide;ulixertinibum;NCGC00378692-05;NSC-800959;N-((1S)-1-(3-chlorophenyl)-2-hydroxyethyl)-4-(5-chloro-2-(propan-2-ylamino)pyridin-4-yl)-1H-pyrrole-2-carboxamide;BDBM50094465;NCGC00378...
CAS No.	869886-67-9
分子式	C₂₁H₂₂Cl₂N₄O₂
分子量	433.33

象形图
警示语
Class
警告声明
UNub
危险声明
Packing Group

搜索质检报告(COA)

搜索MSDS

相关产品